We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Church & Dwight Co
CHD
$23.1B
| $56.9M | 0.13% |
706,123
+387,387
| +122% | +$29.7M |
|
177
PUT
Costco
COST
$415B
| $56.6M | 0.13% |
123,900
+93,000
| +301% | +$45.4M |
|
178
International Flavors & Fragrances
IFF
$19.4B
| $56.2M | 0.13% |
536,435
-853,766
| -61% | -$83.9M |
|
179
PUT
Apple
AAPL
$4.89T
| $56.2M | 0.13% |
432,800
+229,200
| +113% | +$32.8M |
|
180
CALL
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $56.1M | 0.13% |
902,200
+871,600
| +2,848% | +$55.4M |
|
181
AGNC Investment
AGNC
$12.3B
| $55.7M | 0.13% |
5,379,236
+5,317,851
| +8,663% | +$48.6M |
|
182
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $54.8M | 0.12% |
932,977
+283,323
| +44% | +$17.4M |
|
183
Northrop Grumman
NOC
$77B
| $53.9M | 0.12% |
98,738
-68,188
| -41% | -$35.6M |
|
184
Target
TGT
$62.1B
| $53.7M | 0.12% |
+360,521
| New | +$56.6M |
|
185
PUT
Walmart Inc
WMT
$871B
| $53.4M | 0.12% |
1,130,400
-234,300
| -17% | -$11.1M |
|
186
Copa Holdings
CPA
$5.56B
| $53.4M | 0.12% |
642,209
-512,965
| -44% | -$40.4M |
|
|
HZNP
187
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $53.2M | 0.12% |
467,291
-2,039,038
| -81% | -$169M |
|
188
CALL
iShares Semiconductor ETF
SOXX
$44.2B
| $53.1M | 0.12% |
457,500
+381,900
| +505% | +$44.3M |
|
|
PDCE
189
DELISTED
PDC Energy, Inc.
PDCE
| $52.7M | 0.12% |
830,061
-122,142
| -13% | -$8.52M |
|
190
AutoZone
AZO
$48.3B
| $52.5M | 0.12% |
21,298
+8,972
| +73% | +$21.7M |
|
191
Moderna
MRNA
$21.5B
| $52M | 0.12% |
289,642
-380,659
| -57% | -$62.2M |
|
192
Inspire Medical Systems
INSP
$1.42B
| $51.9M | 0.12% |
205,922
-158,515
| -43% | -$33.8M |
|
193
Norwegian Cruise Line
NCLH
$8.89B
| $51.8M | 0.12% |
4,230,052
+1,240,401
| +41% | +$18.7M |
|
194
SL Green Realty
SLG
$3.88B
| $51.5M | 0.12% |
1,527,786
+221,907
| +17% | +$8.44M |
|
195
M&T Bank
MTB
$36.2B
| $50.9M | 0.11% |
350,760
+72,678
| +26% | +$12M |
|
196
LivaNova
LIVN
$4.3B
| $50.5M | 0.11% |
908,691
+447,934
| +97% | +$22.9M |
|
|
CVII
197
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $50.3M | 0.11% |
5,046,108
| – | – |
|
198
PUT
Meta Platforms (Facebook)
META
$1.51T
| $50M | 0.11% |
415,800
-21,200
| -5% | -$2.49M |
|
199
PUT
UnitedHealth
UNH
$382B
| $49.8M | 0.11% |
93,900
+75,100
| +399% | +$39.8M |
|
200
Eli Lilly
LLY
$1.07T
| $49.8M | 0.11% |
136,000
-264,245
| -66% | -$93.7M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.